Second primary malignancies in patients with lymphoma in Denmark after high-dose chemotherapy and autologous haematopoietic stem-cell transplantation: a population-based, retrospective cohort study
Authors:
- 6 September 2023
- journal article
- research article
- Published by Elsevier in The Lancet Haematology
- Vol. 10 (10) , e838-e848
Abstract
No abstract availableKeywords
Funding Information
- Kræftens Bekæmpelse
This publication has 29 references indexed in Scilit:
- Long‐term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphomaBritish Journal of Haematology, 2012
- Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01Journal of Clinical Oncology, 2012
- Danish education registersScandinavian Journal of Public Health, 2011
- The Danish Cancer RegistryScandinavian Journal of Public Health, 2011
- The Danish National Prescription RegistryScandinavian Journal of Public Health, 2011
- Risk Factors for the Development of Secondary Malignancy After High-Dose Chemotherapy and Autograft, With or Without Rituximab: A 20-Year Retrospective Follow-Up Study in Patients With LymphomaJournal of Clinical Oncology, 2011
- The non‐relapse mortality rate for patients with diffuse large B‐cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controlsBritish Journal of Haematology, 2011
- Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphomaLeukemia & Lymphoma, 2009
- High-Dose Therapy and Autologous Hematopoietic Stem-Cell Transplantation Does Not Increase the Risk of Second Neoplasms for Patients With Hodgkin's Lymphoma: A Comparison of Conventional Therapy Alone Versus Conventional Therapy Followed by Autologous Hematopoietic Stem-Cell TransplantationJournal of Clinical Oncology, 2005
- Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patientsAnnals of Oncology, 2004